Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clinuvel Pharmaceuticals Ltd has announced the appointment of Guy van Dievoet as a new director, effective from September 6, 2024. In accordance with listing rule 3.19A.1, the company disclosed that van Dievoet currently holds no registered securities in the company. The notice also confirmed that the director has no interests in any contracts related to the company at this time.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.